我国化妆品不良反应监测工作发展现状及思考

doi:10.19803/j.1672-8629.2021.09.11

中国药物警戒 ›› 2021, Vol. 18 ›› Issue (9): 850-854.
DOI: 10.19803/j.1672-8629.2021.09.11

我国化妆品不良反应监测工作发展现状及思考

李岚, 孔繁瑶, 朱盈, 沈璐^*

国家药品监督管理局药品评价中心,药物警戒研究与评价重点实验室,北京 100022

收稿日期:2020-09-29 出版日期:2021-09-15 发布日期:2021-09-18
通讯作者: ^*沈璐,女,硕士,副主任药师,化妆品不良反应监测。Email: shenlu@cdr-adr.org.cn
作者简介:李岚,女,硕士,主管药师,化妆品不良反应监测。

Developments and Suggestions on Cosmetics Adverse Reaction Monitoring in China

LI Lan, KONG Fanyao, ZHU Ying, SHEN Lu^*

Center for Drug Reevaluation, Key Laboratory for Research and Evaluation of Pharmacovigilance, NMPA, Beijing 100022, China

Received:2020-09-29 Online:2021-09-15 Published:2021-09-18

摘要/Abstract

摘要： 目的分析我国化妆品不良反应监测工作的发展现状和问题。方法对我国化妆品不良反应监测工作的历史进行总结,分析和探讨工作中存在的问题。结果我国化妆品不良反应监测体系和系统已初步建成,化妆品监测工作正努力服务于监管,并从中挖掘科普宣传内容。结论建议完善化妆品不良反应标准体系,加强监测体系建设并强化落实化妆品注册人和备案人的主体责任等,以推动我国化妆品不良反应监测工作深入开展。

关键词: 化妆品, 不良反应监测, 问题, 发展现状

Abstract: Objective To review the developments of and problems with cosmetics adverse reaction monitoring in China. Methods The history of cosmetics adverse reaction monitoring in China was reviewed and the existing problems were analyzed and discussed. Results The management system and monitoring system of cosmetics adverse reactions have been basically established. Professionals in cosmetics adverse reaction monitoring are working hard to serve supervision and popularize the related science. Conclusion It is recommended that the standard system of the cosmetics adverse reactions be improved, the monitoring system be strengthened and the responsibilities of cosmetics registrants and filing persons be fully implemented so as to boost the development of cosmetics adverse reaction monitoring.

Key words: cosmetics, adverse reaction monitoring, questions, development status

中图分类号:

R951

李岚, 孔繁瑶, 朱盈, 沈璐. 我国化妆品不良反应监测工作发展现状及思考[J]. 中国药物警戒, 2021, 18(9): 850-854.

LI Lan, KONG Fanyao, ZHU Ying, SHEN Lu. Developments and Suggestions on Cosmetics Adverse Reaction Monitoring in China[J]. Chinese Journal of Pharmacovigilance, 2021, 18(9): 850-854.

导出引用管理器 EndNote|Ris|BibTeX

链接本文: https://zgywjj.magtechjournal.com/CN/10.19803/j.1672-8629.2021.09.11

https://zgywjj.magtechjournal.com/CN/Y2021/V18/I9/850

参考文献

[1] Liu YL, Deng J.Present and future of cosmetics in China[J].China Detergent & Cosmetics(日用化学品科学), 2016, 39(1): 1-8.
[2] Shen L, Kong FY, Lu CF, et al.Introduction to cosmetic product safety report in European Union[J]. Chinese Journal of Pharmacovigilance(中国药物警戒), 2016, 119(11): 678-681.
[3] Ministry of Health of the People's Republic of China. Regulations concerning the hygiene supervision over cosmetics[EB/OL]. (1989-11-13)[2020-10-21]. http://www.nhc.gov.cn/fzs/s3576/200804/4c507f465c00488f8628ee49d15d480f.shtml.
[4] The State Council. Decree of the state council of the people’s republic of China(no.727)- regulations on supervision and administration of cosmetics[EB/OL].(2020-06-29)[2020-10-21]. http://www.gov.cn/zhengce/zhengceku/2020-06/29/content_5522593.htm.
[5] National Medical Products Administration. Monitoring administration measure on adverse cosmetic reaction(draft for comments) [EB/OL].(2020-09-28)[2020-10-21]. https://www.nmpa.gov.cn/hzhp/hzhpfgwj/hzhpgzwj/20200928103936177.html.
[6] Lu CF, Shen L, Tian YJ, et al.Exploration on the model of cosmetic adverse reactions monitoring in China[J]. Chinese Journal of Pharmacovigilance(中国药物警戒), 2014, 11(12): 743-745.
[7] National Medical Products Administration. Guiding opinions on accelerating the construction of cosmetics adverse reaction monitoring system[EB/OL].(2011-11-24)[2020-10-21]. https://www.nmpa.gov.cn/xxgk/fgwj/gzwj/gzwjhzhp/20111124120001308.html.
[8] Center for Drug Reevaluation. The handover of cosmetics adverse reaction monitoring work and monitoring pilot work kick-off meeting was held in Beijing[EB/OL].(2014-06-30)[2020-10-21].http://www.cdr-adr.org.cn/center_news/201406/t20140630_42577.html.
[9] Center for Drug Reevaluation. NMPA and National Center fully launched a pilot project for cosmetics adverse reactions monitoring. (2015-01-19)[2020-10-21].. NMPA and National Center fully launched a pilot project for cosmetics adverse reactions monitoring. (2015-01-19)[2020-10-21].http://http://www.cdr-adr.org.cn/center_news/201501/t20150119_42704.html.
[10] Lu H, Luo L.A brief discussion of the construction of sentinel unit of cosmetic adverse reaction monitoring[J]. Medical Information(医学信息), 2015, 28(46): 282-283.
[11] National Medical Products Administration. Notice on the announcement of the first batch of national cosmetics adverse reaction monitoring and evaluation bases[EB/OL].(2018-05-28)[2020-10-21]. https://www.nmpa.gov.cn/xxgk/fgwj/gzwj/gzwjhzhp/20180528175001919.html.
[12] Mu X, Chen LY, De XH, et al.Present situation of cosmetic adverse reactions information collecting system and strategies for improvement in China[J]. Flavour Fragrance Cosmetics(香料香精化妆品), 2018, 169(4): 40-44.
[13] Shan XH, Shen L, Chi G, et al.Study on experimental work of monitoring of adverse reactions of cosmetics in China[J]. China Health Industry(中国卫生产业), 2018, 15(8): 177-180.
[14] Wu PH, Yu CY, Liu DH.Overview of cosmetic safety risks[J].Capital Food Medicine(首都食品与医药), 2016. 23(6): 6.
[15] Center for Drug Reevaluation. Tips on the use of hair dye cosmetics[EB/OL].(2018-03-16)[2020-10-21].http://www.cdr-adr.org.cn/hzp_1/Cosmetics_aqjs/Cosmetics_aqjs_xxts/201803/t20180316_36937.html.
[16] Center for Drug Reevaluation. Tips on the use of sunscreen cosmetics[EB/OL].(2019-06-21)[2020-10-21]. http://www.cdr-adr.org.cn/hzp_1/Cosmetics_aqjs/Cosmetics_aqjs_xxts/201906/t20190621_36936.html.
[17] Center for Drug Reevaluation. National center reminds you of safe sun protection[EB/OL].(2019-06-21)[2020-10-21]. http://www.cdr-adr.org.cn/center_news/201906/t20190621_42458.html.
[18] Ministry of Health of the People’s Republic of China. Diagnostic criteria and principles of management of skin diseases induced by cosmetics[S]. Beijing: Standards Press of China, 1998.
[19] Shan XH, Chi G, Jin D, et al.Investigation and research on awareness of adverse drug reactions to cosmetics in medical institutions in China[J]. China Health Industry(中国卫生产业), 2018, 15(9): 168-170.
[20] Lu CF, Cui XK, Liu WW, et al.Considerations on monitoring the adverse reaction of cosmetics[J]. Journal of Environmental Hygiene(环境卫生学杂志), 2018, 8(2): 158-161.
[21] Shandong Medical Products Administration, Shandong Health Commission. Notice on the announcement of measures for the manage-ment of sentinel for the monitoring of adverse drug and cosmetic reactions of Shandong Province[J]. Gazette of the People’s Government of Shandong Province(山东省人民政府公报), 2019, 692(32): 115-118.

我国化妆品不良反应监测工作发展现状及思考

Developments and Suggestions on Cosmetics Adverse Reaction Monitoring in China

PDF (PC)

可视化

摘要/Abstract

引用本文

使用本文

参考文献

相关文章 15

编辑推荐

Metrics

[1]	李文龙, 贾娟娟, 黄海伟, 姚静, 张春青, 王岩, 张辉. 我国放射性药品发展现状与展望[J]. 中国药物警戒, 2025, 22(1): 37-42.
[2]	王丹, 董铎, 田春华. 我国药物警戒制度发展历程和思考[J]. 中国药物警戒, 2024, 21(7): 735-740.
[3]	朱盈, 沈璐, 李岚, 吴建民, 高晓洁. 新法规体系下我国牙膏不良反应监测工作分析与思考[J]. 中国药物警戒, 2024, 21(2): 219-222.
[4]	卫红涛, 沈素, 李丹丹, 廖音. 705例神经内科问题医嘱的帕累托图分析[J]. 中国药物警戒, 2022, 19(8): 900-903.
[5]	刘敏, 裴小静, 王海学. 我国药物临床试验期间可疑且非预期严重不良反应快速报告的常见问题及建议[J]. 中国药物警戒, 2022, 19(2): 176-179.
[6]	王轶, 任经天. 苯溴马隆与药物性肝损伤的获益-风险分析和思考[J]. 中国药物警戒, 2022, 19(2): 189-192.
[7]	于洪礼, 逄瑜, 邵波, 肖爱丽, 于冬梅. 我国基本药物不良反应报告与监测情况浅析[J]. 中国药物警戒, 2021, 18(8): 766-768.
[8]	李岚, 孔繁瑶, 朱盈, 沈璐. 我国化妆品安全风险信息交流机制分析与思考[J]. 中国药物警戒, 2021, 18(8): 769-771.
[9]	王丹, 任经天, 吴桂芝, 熊玮仪, 汤韧, 逄瑜, 樊蓉, 杨乐. 《药物警戒质量管理规范》对我国构建药物警戒制度的意义[J]. 中国药物警戒, 2021, 18(6): 501-503.
[10]	黄政凯, 张冰, 林志健, 张晓朦, 张丹, 殷玉玲. 蒽醌类中药的安全问题分析及合理应用思考[J]. 中国药物警戒, 2021, 18(6): 532-536.
[11]	黄先开, 董银卯, 孟宏, 左敏, 何一凡, 孟禹熙, 贾焱. 国际化妆品监管合作组织助力化妆品监管科学国际化[J]. 中国药物警戒, 2021, 18(5): 401-405.
[12]	朱盈, 沈璐, 李岚, 孔繁瑶, 吴建民. 美国化妆品不良反应监测制度研究及启示[J]. 中国药物警戒, 2021, 18(12): 1148-1149.
[13]	王丹, 任经天, 董铎, 彭丽丽, 刘巍. 药品不良反应监测年度报告十年趋势分析[J]. 中国药物警戒, 2020, 17(5): 276-283.
[14]	袁林, 高燕, 路长飞. 我国建立药物警戒制度的初步思考[J]. 中国药物警戒, 2020, 17(11): 749-752.
[15]	桑媛, 吴世福, 路长飞, 谢彦军, 崔小康, 许莉莉, 刘文文, 霍艳飞. 检查视角下生产企业药品不良反应报告与监测的问题及思考[J]. 中国药物警戒, 2019, 16(4): 215-218.